Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

25-Hydroxyvitamin D level is associated with mortality in patients with critical COVID-19: a prospective observational study in Mexico City

  • Received : 2021.03.28
  • Accepted : 2021.07.27
  • Published : 2021.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

BACKGROUND/OBJECTIVES: Considering the high number of deaths from coronavirus disease 2019 (COVID-19) in Latin American countries, together with multiple factors that increase the prevalence of vitamin D deficiency, we aimed to determine 25-hydroxyvitamin D (25[OH]D) levels and its association with mortality in patients with critical COVID-19. SUBJECTS/METHODS: This was a prospective observational study including adult patients with critical COVID-19. Data, including clinical characteristics and 25(OH)D levels measured at the time of intensive care unit admission, were collected. All patients were followed until hospital discharge or in-hospital death. The patients were divided into those surviving and deceased patient groups, and univariate and multivariate logistic regression analyses were performed to determine independent predictors of in hospital mortality. RESULTS: The entire cohort comprised 94 patients with critical COVID-19 (males, 59.6%; median age, 61.5 years). The median 25(OH)D level was 12.7 ng/mL, and 15 (16%) and 79 (84%) patients had vitamin D insufficiency and vitamin D deficiency, respectively. The median serum 25(OH)D level was significantly lower in deceased patients compared with surviving (12.1 vs. 18.7 ng/mL, P < 0.001). Vitamin D deficiency was present in 100% of the deceased patients. Multivariate logistic regression analysis revealed that age, body mass index, other risk factors, and 25(OH)D level were independent predictors of mortality. CONCLUSIONS: Vitamin D deficiency was present in 84% of critical COVID-19 patients. Serum 25(OH)D was independently associated with mortality in critical patients with COVID-19.

Keywords

Acknowledgement

This work was supported by a Mexican Federal Funds Grant (HIM 2020/131).

References

  1. World Health Organization (WHO). COVID-19 [Internet]. Geneva: World Health Organization; 2021 [cited 2021 November 3]. Available from: https://covid19.who.int/.
  2. Gobierno de Mexico. Datos Abiertos Direccion General de Epidemiologia [Internet]. Mexico City: Gobierno de Mexico; 2021 [cited 2021 November 3]. Available from: https://datos.covid-19.conacyt.mx/.
  3. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 2020;41:145-51.
  4. Laird E, Rhodes J, Kenny RA. Vitamin D and inflammation: potential implications for severity of COVID-19. Ir Med J 2020;113:81.
  5. Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol 2014;144 Pt A:138-45. https://doi.org/10.1016/j.jsbmb.2013.11.003
  6. Contreras-Manzano A, Villalpando S, Robledo-Perez R. Vitamin D status by sociodemographic factors and body mass index in Mexican women at reproductive age. Salud Publica Mex 2017;59:518-25. https://doi.org/10.21149/8080
  7. Flores M, Sanchez-Romero LM, Macias N, Lozada A, Diaz E, Barquera SE. Concentraciones sericas de vitamina D en ninos, adolescentes y adultos mexicanos. Resultados de la ENSANUT 2006 [Internet]. Cuernavaca: Instituto Nacional de Salud Publica; 2011 [cited 2021 May 23]. Available from: https://www.insp.mx/images/stories/Centros/cinys/Docs/111202_ReporteVitaminaD.pdf.
  8. Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients 2015;7:4240-70. https://doi.org/10.3390/nu7064240
  9. Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001;97:3951-9. https://doi.org/10.1182/blood.V97.12.3951
  10. Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, Davidson DJ, Donis RO. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One 2011;6:e25333. https://doi.org/10.1371/journal.pone.0025333
  11. Karahan S, Katkat F. Impact of serum 25(OH) vitamin D level on mortality in patients with COVID-19 in Turkey. J Nutr Health Aging 2021;25:189-96. https://doi.org/10.1007/s12603-020-1479-0
  12. De Smet D, De Smet K, Herroelen P, Gryspeerdt S, Martens GA. Serum 25(OH)D level on hospital admission associated with COVID-19 stage and mortality. Am J Clin Pathol 2021;155:381-8. https://doi.org/10.1093/ajcp/aqaa252
  13. Alguwaihes AM, Al-Sofiani ME, Megdad M, Albader SS, Alsari MH, Alelayan A, Alzahrani SH, Sabico S, Al-Daghri NM, Jammah AA. Diabetes and COVID-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study. Cardiovasc Diabetol 2020;19:205. https://doi.org/10.1186/s12933-020-01184-4
  14. Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A, Martucci G, Pilz S, Malle O. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr 2020;74:1498-513. https://doi.org/10.1038/s41430-020-0558-y
  15. Sassi F, Tamone C, D'Amelio P. Vitamin D: Nutrient, Hormone, and Immunomodulator. Nutrients 2018;10:1656. https://doi.org/10.3390/nu10111656
  16. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011;7:337-45. https://doi.org/10.1038/nrendo.2010.226
  17. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008;181:7090-9. https://doi.org/10.4049/jimmunol.181.10.7090
  18. Vanherwegen AS, Gysemans C, Mathieu C. Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin North Am 2017;46:1061-94. https://doi.org/10.1016/j.ecl.2017.07.010
  19. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010;39:365-79. https://doi.org/10.1016/j.ecl.2010.02.010
  20. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 2020;12:988. https://doi.org/10.3390/nu12040988
  21. Brito A, Cori H, Olivares M, Fernanda Mujica M, Cediel G, Lopez de Romana D. Less than adequate vitamin D status and intake in Latin America and the Caribbean: a problem of unknown magnitude. Food Nutr Bull 2013;34:52-64. https://doi.org/10.1177/156482651303400107
  22. Carrillo-Vega MF, Garcia-Pena C, Gutierrez-Robledo LM, Perez-Zepeda MU. Vitamin D deficiency in older adults and its associated factors: a cross-sectional analysis of the Mexican Health and Aging Study. Arch Osteoporos 2017;12:8. https://doi.org/10.1007/s11657-016-0297-9
  23. Mendes MM, Hart KH, Botelho PB, Lanham-New SA. Vitamin D status in the tropics: is sunlight exposure the main determinant? Nutr Bull 2018;43:428-34. https://doi.org/10.1111/nbu.12349
  24. Norval M, Wulf HC. Does chronic sunscreen use reduce vitamin D production to insufficient levels? Br J Dermatol 2009;161:732-6. https://doi.org/10.1111/j.1365-2133.2009.09332.x
  25. Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol 2008;84:539-49. https://doi.org/10.1111/j.1751-1097.2007.00226.x
  26. Vranic L, Mikolasevic I, Milic S. Vitamin D deficiency: consequence or cause of obesity? Medicina (Kaunas) 2019;55:541. https://doi.org/10.3390/medicina55090541
  27. Chang SW, Lee HC. Vitamin D and health - The missing vitamin in humans. Pediatr Neonatol 2019;60:237-44. https://doi.org/10.1016/j.pedneo.2019.04.007
  28. Lopez-Feldman A, Heres D, Marquez-Padilla F. Air pollution exposure and COVID-19: a look at mortality in Mexico City using individual-level data. Sci Total Environ 2021;756:143929. https://doi.org/10.1016/j.scitotenv.2020.143929
  29. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, Zheng SG. Vitamin D and chronic diseases. Aging Dis 2017;8:346-53. https://doi.org/10.14336/AD.2016.1021
  30. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020;369:m1985.
  31. Rezende LF, Thome B, Schveitzer MC, Souza-Junior PR, Szwarcwald CL. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil. Rev Saude Publica 2020;54:50. https://doi.org/10.11606/s1518-8787.2020054002596
  32. Martinez-Zavala N, Lopez-Sanchez GN, Vergara-Lopez A, Chavez-Tapia NC, Uribe M, Nuno-Lambarri N. Vitamin D deficiency in Mexicans have a high prevalence: a cross-sectional analysis of the patients from the Centro Medico Nacional 20 de Noviembre. Arch Osteoporos 2020;15:88. https://doi.org/10.1007/s11657-020-00765-w
  33. Acharya R, Poudel D, Bowers R, Patel A, Schultz E, Bourgeois M, Paswan R, Stockholm S, Batten M, Kafle S, et al. Low serum albumin predicts severe outcomes in COVID-19 infection: a single-center retrospective case-control study. J Clin Med Res 2021;13:258-67. https://doi.org/10.14740/jocmr4507
  34. Munshi R, Hussein MH, Toraih EA, Elshazli RM, Jardak C, Sultana N, Youssef MR, Omar M, Attia AS, Fawzy MS, et al. Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. J Med Virol 2021;93:733-40. https://doi.org/10.1002/jmv.26360
  35. Vassiliou AG, Jahaj E, Pratikaki M, Orfanos SE, Dimopoulou I, Kotanidou A. Low 25-hydroxyvitamin D levels on admission to the intensive care unit may predispose COVID-19 pneumonia patients to a higher 28-day mortality risk: a pilot study on a Greek ICU cohort. Nutrients 2020;12:3773. https://doi.org/10.3390/nu12123773
  36. Allegra A, Tonacci A, Pioggia G, Musolino C, Gangemi S. Vitamin deficiency as risk factor for SARS-CoV-2 infection: correlation with susceptibility and prognosis. Eur Rev Med Pharmacol Sci 2020;24:9721-38.
  37. Cano F, Gajardo M, Freundlich M. Renin angiotensin axis, angiotensin converting enzyme 2 and coronavirus. Rev Chil Pediatr 2020;91:330-8. https://doi.org/10.32641/rchped.v91i3.2548
  38. Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct Target Ther 2020;5:84. https://doi.org/10.1038/s41392-020-0191-1
  39. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017;356:i6583.